| Also known as: |
CR1/CR2 |
| Category: |
Antibodies |
| Subcategory: |
Mnoclonal antibodies |
| Gene name: |
CR1/CR2 |
| Clonality: |
Monoclonal |
| Immunoglobulin isotype: |
IgG2a |
| Host organism: |
Mouse (Mus musculus) |
| Species reactivity: |
Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby, N/A |
| Specificity and cross-reactivity: |
Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited, This particular antibody might cross react with speacies outside of the listed ones, N/A |
| Form/Appearance: |
containing 0, 02% sodium azide, 1 ml (100 ug/ml) 0, 1% bovine serum albumin and 0, 2 um filtered antibody solution in PBS |
| Storage and shipping: |
Temperature variations in the range between +1C to +7C are tolerable, Under recommended storage conditions, product is stable for one year, Product should be stored at Keep the antibody refrigerated at +4 degrees Celsius |
| Tested applications:: |
Immunofluorescence (IF), Immunoprecipitation (IP), Western Blot (WB), Flow Cytometry (FC/FACS) |
| Test: |
A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or |
| Latin name: |
Mus musculus |
| Gene target: |
mAb 7E9, CR1/CR2 |
| Short name: |
Mouse, mAb 7E9, CR1/CR2 |
| Technique: |
mouses, Mouse |
| Species: |
Mouses, Mouse |
| Alternative name: |
Mouse, monoclonal 7E9, complement component (3b/4b) receptor 1 (Knops blood group)/complement component (3d/Epstein Barr virus) receptor 2 |
| Alternative technique: |
murine |
| Alternative to gene target: |
C3BR and C4BR and CD35 and KN, C3DR and CD21 and CR and CVID7 and SLEB9, CR1 and IDBG-106358 and ENSG00000203710 and 1378, CR2 and IDBG-106349 and ENSG00000117322 and 1380, CR2 and IDBG-629275 and ENSBTAG00000038496 and 100335830, Cell surfaces, Cell surfaces, Cr2 and IDBG-209389 and ENSMUSG00000026616 and 12902, alternative pathway and biological process this GO :0045959 and negative regulation of complement activation, classical pathway and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0030183 and B cell differentiation and biological process this GO :0042100 and B cell proliferation and biological process this GO :0042113 and B cell activation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043235 and receptor complex and cellular component this GO :0045087 and innate immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, classical pathway and biological process this GO :0009986 and cell surface and cellular component this GO :0030449 and regulation of complement activation and biological process this GO :0045087 and innate immune response and biological process this GO :0045957 and negative regulation of complement activation, classical pathway and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :1900004 and negative regulation of serine-type endopeptidase activity and biological process this GO :1900005 and positive regulation of serine-type endopeptidase activity and biological process, complement component (3b/4b) receptor 1 (Knops blood group), complement component C3b receptor activity, protein homodimerization activity, this GO :0001848 and complement binding and molecular function this GO :0002430 and complement receptor mediated signaling pathway and biological process this GO :0003677 and DNA binding and molecular function this GO :0004872 and receptor activity and molecular function this GO :0004875 and complement receptor activity and molecular function this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0006955 and immune response and biological process this GO :0006958 and complement activation, this GO :0001848 : complement binding, this GO :0001848 : complement binding and also this GO :0003677 : DNA binding and also this GO :0004872 : receptor activity and also this GO :0004875 : complement receptor activity and also this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005515 : protein binding and also this GO :0042803 : protein homodimerization activity, this GO :0001851 and complement component C3b binding and molecular function this GO :0001855 and complement component C4b binding and molecular function this GO :0001861 and complement component C4b receptor activity and molecular function this GO :0002430 and complement receptor mediated signaling pathway and biological process this GO :0004877 and complement component C3b receptor activity and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006958 and complement activation, this GO :0001851 : complement component C3b binding, this GO :0001851 : complement component C3b binding and also this GO :0001855 : complement component C4b binding and also this GO :0001861 : complement component C4b receptor activity and also this GO :0004877 : complement component C3b receptor activity, this GO :0001855 : complement component C4b binding, this GO :0001861 : complement component C4b receptor activity, this GO :0003677 : DNA binding, this GO :0004872 : receptor activity, this GO :0004875 : complement receptor activity, this GO :0004877 : complement component C3b receptor activity, this GO :0004888 : transmembrane signaling receptor activity, this GO :0005515 : protein binding, this GO :0042803 : protein homodimerization activity, 407126, complement component (3d/Epstein Barr virus) receptor 2 |
| Identity: |
2334 |
| Gene: |
CR1 |
More about : CR1 |
| Long gene name: |
complement C3b/C4b receptor 1 (Knops blood group) |
| Synonyms gene name: |
complement component (3b/4b) receptor 1, including Knops blood group system complement component (3b/4b) receptor 1 (Knops blood group) complement component 3b/4b receptor 1 (Knops blood group) |
| Synonyms: |
CD35 KN |
| Locus: |
1q32, 2 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
Y00816 |
| Entrez gene record: |
1378 |
| Pubmed identfication: |
1708809 |
| RefSeq identity: |
NM_000573 |
| Classification: |
Sushi domain containing Complement system CD molecules Blood group antigens |
| Havana BLAST/BLAT: |
OTTHUMG00000036311 |
| Locus Specific Databases: |
Blood Group Antigen Mutation Database LRG_814 |